A detailed history of Brevan Howard Capital Management LP transactions in Xencor Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 18,699 shares of XNCR stock, worth $431,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,699
Previous 20,499 8.78%
Holding current value
$431,385
Previous $388,000 3.09%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.7 - $21.65 $28,260 - $38,970
-1,800 Reduced 8.78%
18,699 $376,000
Q2 2024

Aug 14, 2024

BUY
$18.21 - $24.5 $373,286 - $502,225
20,499 New
20,499 $388,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.38B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.